Nucleic Acid Internal Control Reagents for NAT Assay Reliability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid testing (NAT) assays face challenges in identifying robust internal control sequences, primers, and probes that are sensitive, reproducible, and versatile enough to detect and quantify a wide array of target sequences, due to issues like hairpins, A/T runs, and narrow reaction condition ammenability.

Innovation Solution

The development of internal control reagents, including polynucleotides, oligonucleotides, and kits that provide highly sensitive and reproducible nucleic acid sequences, primers, and probes, such as those with specific sequences (SEQ ID NOs: 1, 8, 9, 10, 11, 12, 13, 14, 15) and variants, for use in nucleic acid amplification reactions, including quantitative PCR, to serve as templates, primers, and probes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional internal control nucleic acid sequences are used, then the assay can detect target nucleic acids, but false positives or false negatives occur due to hairpins, A/T runs, or G/C runs affecting amplification and probe hybridization

Engineering Contradiction:
Improveaccuracy of detectionVSAvoidhairpins, A/T runs, G/C runs
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the nucleic acid sequence composition to achieve optimal GC content (40-60%) and avoid problematic regions. The internal control sequences are specifically designed with controlled nucleotide composition to prevent hairpin formation and ensure proper annealing temperatures, thereby eliminating false positives/negatives while maintaining detection accuracy

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates simplified copy versions of internal control sequences that replicate the essential amplification and hybridization functions without the harmful structural features. These copied sequences are optimized to lack hairpins and extreme A/T or G/C runs, providing reliable control signals without the artifacts of conventional sequences

Inventive Principle:
Principle #26Copying

2Measurement precision

If a specific internal control template sequence is designed for high sensitivity, then detection of low copy numbers is achieved, but the control becomes incompatible with multiplex reactions or requires extensive empirical validation

Engineering Contradiction:
Improvedetection sensitivityVSAvoidcompatibility across reaction conditions
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent achieves universality by designing internal control sequences that function reliably across diverse reaction conditions and multiplex assays. The sequences are engineered with balanced GC content and optimal lengths to maintain consistent amplification efficiency whether used alone or with multiple target sequences, eliminating the need for separate validation for each application

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent optimizes sequence parameters including length (100-1000 nucleotides), GC content (40-60%), and nucleotide distribution to achieve broad compatibility. These parameter adjustments ensure the internal control maintains high detection sensitivity while adapting to various thermal cycling conditions and multiplex reaction environments without requiring extensive re-validation

Inventive Principle:
Principle #35Parameter changes

3Productivity

If internal control sequences are optimized for narrow reaction conditions, then amplification efficiency is high, but the control cannot be used in a variety of multiplex reactions

Engineering Contradiction:
Improveamplification efficiencyVSAvoidrange of reaction conditions
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent balances amplification efficiency with versatility by optimizing key parameters: GC content set to 40-60% for stable yet adaptable hybridization, sequence length adjusted to 100-1000 nucleotides for efficient amplification across conditions, and nucleotide distribution engineered to avoid extreme temperature requirements. This parameter optimization enables the internal control to maintain high productivity across broad reaction condition ranges

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These internal control reagents exhibit high sensitivity and reproducibility, enabling accurate detection and quantification of target sequences across various conditions, improving the reliability of NAT assays and allowing for multiplex reactions.

Implementation Method 1

polynucleotides that can be used as templates in nucleic acid amplification reactions

Methodology Applied
Scientific EffectNucleic acid amplification:

Implementation Method 2

quantitative PCR

Methodology Applied
Scientific EffectPCR:

Implementation Method 3

contacting the template sequence with at least one primer that specifically hybridizes to the template sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 4

extending the primer, thus producing an amplicon of the template sequence

Methodology Applied
Scientific EffectDNA synthesis:

Implementation Method 5

contacting the amplicon with a probe, wherein the probe binds to the amplicon

Methodology Applied
Scientific EffectHybridization:

Implementation Method 6

The probe comprises a fluorophore and a quencher

Methodology Applied
Scientific EffectFluorescence detection: Fluorescence

Data Source

PatentEP3486332B1Nucleic acids for nucleic acid amplification
Publication Date: 2023.04.26 BECTON DICKINSON & CO
  • EP3486332B1 patent drawingFigure 1
  • EP3486332B1 patent drawingFigure 2A
  • EP3486332B1 patent drawingFigure 2B

AI summary

The present invention relates to nucleic acids sequences that can be used for nucleic acid amplification, for example quantitative nucleic acid amplification.